| HS Code | 926180 |
| Product Name | ExxonMobil IPA Pharmacopoeia |
| Chemical Name | Isopropyl alcohol (2-propanol) |
| Cas Number | 67-63-0 |
| Molecular Formula | C3H8O |
| Molecular Weight | 60.10 g/mol |
| Purity | ≥99.8% |
| Appearance | Clear, colorless liquid |
| Odor | Characteristic alcoholic odor |
| Boiling Point | 82.5°C |
| Melting Point | -89.5°C |
| Density At 20c | 0.786 g/cm³ |
| Specific Gravity | 0.786 |
| Solubility In Water | Miscible |
| Flash Point Closed Cup | 11.7°C (53.1°F) |
| Autoignition Temperature | 399°C |
| Vapor Pressure At 20c | 33 mmHg (4.4 kPa) |
| Refractive Index At 20c | 1.377 |
As an accredited ExxonMobil IPA Pharmacopoeia factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | ExxonMobil IPA Pharmacopoeia is high-purity isopropyl alcohol, supplied in 20 L pails and 200 L drums for pharmaceutical use. |
| Container Loading (20′ FCL) | 20′ FCL: one full container of ExxonMobil IPA Pharmacopoeia, securely packed in drums, palletized, and stowed for safe transit. |
| Shipping | ExxonMobil IPA Pharmacopoeia ships as UN1219, Isopropanol (Isopropyl alcohol), Class 3, Packing Group II. It must be transported in approved drums or IBCs with proper flammable labeling, segregation, and documentation. Ensure compliance with modal regulations—road, rail, sea, or air—due to its highly flammable nature. |
| Storage | Store ExxonMobil IPA Pharmacopoeia in tightly closed, original containers in a cool, dry, well-ventilated area, away from heat, sparks, open flames, and strong oxidizers. Ensure containers remain upright and protected from sunlight. Follow local flammable liquid storage regulations, and keep the area clean, with accessible spill containment and eyewash facilities for safety. |
| Shelf Life | Shelf life is typically 24 months from manufacture when stored in original, tightly sealed containers under recommended conditions. |
During the final purification of a sparingly water-soluble free acid intended for oral solid dosage manufacture, ExxonMobil IPA Pharmacopoeia is charged into a 3000 L glass-lined reactor, heated to 65–70 °C, and held under 10–20 kPa nitrogen overpressure until the crude active is fully dissolved. The hot solution is clarified through a 0.45 µm polyethersulfone cartridge followed by a 0.22 µm sterilizing-grade capsule to remove insoluble process-related particles and microbial fragments before crystallisation. The batch is cooled to 2–5 °C at a linear ramp of 0.5–1.0 K/min; this cooling band is selected because faster cooling produces a bimodal crystal-size distribution and slower cooling reduces throughput on a 3000 L scale. Seed crystals are introduced as a slurry at 2–5 wt% relative to batch mass when the solution reaches approximately 35–40 °C, and the slurry is milled under nitrogen to avoid isopropanol vapour accumulating above 2.0 vol%. After a 6–10 h hold at 2–5 °C, the suspension is transferred to an agitated nutsche filter-dryer with jacket temperature controlled at 40–50 °C and vacuum at 20–30 kPa absolute; intermittent agitation at 5–10 rpm prevents crusting while avoiding particle attrition. Residual solvent in the dried active is measured by static headspace gas chromatography in accordance with USP 467, and isopropanol is controlled against ICH Q3C because it is a Class 3 solvent with a permitted daily exposure of 50 mg/day. A conservative release limit of 5000 ppm is used for the active when formulators may subsequently blend it into high-dose oral tablets. Water uptake from ambient air is not permitted to enter the dryer because isopropanol-water mixtures alter the crystal habit of the final form; the dryer is therefore maintained under 10–20 kPa nitrogen overpressure until the product is discharged into polyethylene-lined stainless steel drums.
In presaturated wipes used for transfer-line and laminar-airflow cart disinfection, the active solution is prepared in a closed 316L stainless steel mixing skid by blending ExxonMobil IPA Pharmacopoeia with Purified Water to a final isopropanol concentration of 70% (v/v) at 20 °C. The 30% aqueous fraction slows evaporation sufficiently to maintain wet contact on stainless steel for 1–3 min; concentrated isopropanol above 90% evaporates too rapidly to denature vegetative bacterial proteins and should not be regarded as a surface disinfectant with equivalent efficacy. Release of the blended solution includes density at 20 °C between 0.785 g/cm³ and 0.789 g/cm³, refractive index between 1.376 and 1.378, and water content by Karl Fischer below 0.2 wt% before dilution. Bactericidal activity is verified in quantitative suspension testing under EN 1276 with a 5 min contact time for Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Enterococcus hirae; fungicidal activity is assessed under EN 1650 against Candida albicans and Aspergillus brasiliensis. The blended solution is sterile-filtered through a 0.22 µm membrane and metered into a continuous wipe saturator that maintains an add-on of 2.5–3.0 g solution per 1 g of spunlace polypropylene/polyethylene terephthalate fabric. Lower add-on results in edge-dry wipes that fail contact-time requirements; higher add-on produces dripping and transfer-line liquid residues that increase the risk of particle adhesion. For hand-hygiene stations using the same solvent, the WHO IPA-based formulation is applied at final concentrations of 75% (v/v) isopropanol, 1.45% (v/v) glycerol, and 0.125% (v/v) hydrogen peroxide. Laminated foil or high-barrier polyester overwrap is required for shelf-life; accelerated storage at 40 °C/75% RH for 90 days is used to verify alcohol retention, and an aluminium barrier overwrap is added if gravimetric alcohol loss exceeds 5%.
Where dried root or seed biomass contains poorly water-soluble triterpene acids and neutral glycosides, aqueous isopropanol at 50–70% (v/v) is selected because the water activity suppresses co-extraction of chlorophyll and high-molecular-weight pectin while the alcohol fraction maintains solubility of the target aglycones. ExxonMobil IPA Pharmacopoeia is diluted with Purified Water in a solvent preparation tank; the extraction is run in a 6-stage continuous countercurrent extractor with screw-press dewatering at a solvent-to-dry-biomass ratio of 6:1 to 10:1 L/kg, jacket temperature 50–60 °C, and residence time 90–120 min. The miscella is clarified through a 0.45 µm polypropylene depth filter and concentrated in a wiped-film evaporator at 25–30 kPa absolute and 40–50 °C to remove isopropanol without thermally degrading heat-sensitive aglycones. The concentrate is adjusted with fresh solvent to 70–75% (v/v) isopropanol and held at 4 °C for 12–24 h; this cold-settling step precipitates residual polysaccharides and pectin fragments that otherwise increase viscosity and block downstream spray-dryer nozzles. Centrifugal filtration at 3000×g removes the sediment, and the clarified concentrate is further evaporated under vacuum not exceeding 60 °C until the residual isopropanol falls below the limit appropriate for the botanical extract or the finished dosage form. Peroxide content is monitored before bulk storage; if the peroxide number exceeds 2 mg/kg, the solvent batch is rejected for extraction because peroxide-initiated oxidation can alter chromophore and assay profiles of the final extract. The use of pharmacopoeia-grade alcohol in this operation is justified by the low non-volatile residue and low heavy-metal profile required when the extract is later spray-dried and formulated into hard-shell capsules or coated tablets.
The use of 70% (v/v) isopropanol or a 70:30 isopropanol-water solution prepared from ExxonMobil IPA Pharmacopoeia provides rapid reduction of vegetative bacteria and enveloped viruses on 316L stainless steel, glass, and epoxy surfaces in ISO 14644-1 Grade C and Grade D pharmaceutical cleanrooms, but the solution cannot be assigned sporicidal action. Quantitative suspension testing under EN 1276 supports bactericidal activity at 5 min contact against the standard test organisms, whereas Bacillus subtilis spore reduction under EN 13704 at practical production contact times of 5–15 min is typically below the 3 log10 reduction required for a sporicidal claim. This limitation dictates the design of the disinfection programme: 70% isopropanol is used for routine transfer-point and glove-port wiping, while 6% hydrogen peroxide or 0.5% sodium hypochlorite is rotated at defined weekly intervals and after any spore excursion. For Grade A/B use, the alcohol is filtered through a 0.22 µm sterilizing-grade capsule into presterilised stainless steel or fluoropolymer containers, and the filtered solution is applied at 25–30 mL/m² to the surface using polyester knitted wipes that are double-bagged and autoclaved before entry. Contact time is restricted to 1–3 min for vegetative organisms because longer wet contact damages acrylic and polycarbonate laminate surfaces. Repeated wiping of PVC strip curtains causes plasticizer migration and progressive loss of clarity; chemical compatibility of hard surfaces is evaluated under ASTM D543-21 before the alcohol is approved for cleaning. Incoming solvent and the filtered solution are tested for bioburden and endotoxin using Ph. Eur. 2.6.12, Ph. Eur. 2.6.13, and Ph. Eur. 2.6.14; an in-process alert limit of 0.25 EU/mL is typical for Grade A transfer isolators. These controls do not convert isopropanol into a sporicide, and the operational boundary is explicitly recorded in the site sanitisation master plan.
For modified-release tablet coating, a 5–10 wt% ethylcellulose solution is prepared by adding the polymer gradually into ExxonMobil IPA Pharmacopoeia under a high-shear disperser with a nitrogen sweep; plasticizers such as dibutyl sebacate or triethyl citrate are incorporated at 10–25% of dry polymer mass to prevent brittle film formation. The solution is held at 20–25 °C because viscosity above 150 mPa·s reduces two-fluid nozzle atomization and creates visible droplet-induced surface roughness on the tablet. A 48-inch perforated coating pan is operated at inlet air temperature 50–60 °C, exhaust air temperature 35–40 °C, pan speed 4–12 rpm, spray rate 6–12 L/h, and atomising air pressure 1.0–1.5 bar. Process exhaust humidity above 60% RH causes water absorption into the solvent system, premature phase separation of the ethylcellulose film, and the surface defect commonly described as orange peel; the coating suite therefore requires independent dehumidification of inlet air. Flammability controls are derived from closed-cup flash point 11.7 °C, lower flammable limit 2.0 vol%, upper flammable limit 12.7 vol%, and autoignition temperature 399 °C; the coating room is classified as a hazardous location, and exhaust lower-flammability-limit monitors alarm at 25% LFL. After the target weight gain is achieved, coated tablets are dried in tray dryers at 40–50 °C for 4–12 h and the residual isopropanol is determined by headspace gas chromatography using USP 467 methodology. The release limit is set below 5000 ppm, consistent with the ICH Q3C Class 3 concentration limit. The use of pharmacopoeia-grade solvent is intended to reduce non-volatile residue that would otherwise remain in the coating film after solvent evaporation.
| Flammability parameter | Value | Reference |
|---|---|---|
| Closed-cup flash point | 11.7 °C | NFPA 325 |
| Lower flammable limit | 2.0 vol% | NFPA 325 |
| Upper flammable limit | 12.7 vol% | NFPA 325 |
| Autoignition temperature | 399 °C | NFPA 325 |
At release testing for single-enantiomer intermediates, normal-phase chiral high-performance liquid chromatography often uses a mobile phase of 2–10% (v/v) isopropanol in n-heptane over a 250 mm × 4.6 mm column packed with 5 µm amylose tris(3,5-dimethylphenylcarbamate). The column temperature is held at 25 °C, the flow rate at 1.0 mL/min, and the injection volume at 10 µL; detection is performed at 210 nm. ExxonMobil IPA Pharmacopoeia is used because the low water specification prevents retention-time drift in normal-phase mode, where water content above 0.2% alters the separation factor and peak symmetry. The mobile phase is filtered through a 0.22 µm polytetrafluoroethylene membrane and vacuum degassed at 50–60 kPa absolute for 5 min; unswept dissolved oxygen and residual trace aldehydes contribute to baseline rise at 210 nm. Chromatographic system suitability follows USP 621, with resolution between critical peak pairs not less than 1.5 and tailing factor not more than 2.0. Liquid-chromatography pump seals and degasser membranes are specified in perfluoroelastomer or polytetrafluoroethylene because prolonged exposure to isopropanol degrades some polyurethane components and releases extractables. Waste lines are grounded and vented to an explosion-proof exhaust system because the organic waste can separate into an isopropanol-rich upper layer with a flash point below ambient. The analytical method is used to release enantiomeric purity data for the same API intermediates that may have been crystallised from isopropanol, creating a closed-loop quality control chain from purification to chromatographic proof of chemical purity.
Competitive ExxonMobil IPA Pharmacopoeia prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618136850665 or mail to sales4@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8618136850665
Email: sales4@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Property | Method | Typical release or limit |
|---|---|---|
| Assay as 2-propanol | ASTM D770-20; Ph. Eur. 2-Propanol | ≥ 99.9% w/w |
| Water content | ASTM E203-16; Ph. Eur. 2.5.12 | ≤ 0.05% w/w |
| Residue after evaporation | Ph. Eur. 2-Propanol | ≤ 10 mg/L |
| Acidity as acetic acid | ASTM D1613-06 | ≤ 0.002% w/w |
| Aldehydes and ketones as acetone | ASTM D770-20; capillary GC | ≤ 0.01% w/w |
| Colour | ASTM D1209-05(2019) | ≤ 10 APHA |
| Distillation range | ASTM D1078-21 | 82.0–83.0 °C |
| Density at 20 °C | ASTM D4052-22 | 0.785–0.786 g/cm³ |
| UV absorbance | Ph. Eur. 2-Propanol | ≤ 0.10 AU at 230–290 nm |
| Attribute | IPA Pharmacopoeia | Technical IPA | Cosmetic IPA | Recovered or denatured IPA |
|---|---|---|---|---|
| Assay by GC | ≥ 99.9% | 99.0–99.9% | 99.0–99.9% | 70–99% |
| Water content | ≤ 0.05% | 0.1–0.5% | 0.1–0.5% | 0.2–2.0% |
| Residue after evaporation | ≤ 10 mg/L | 10–25 mg/L | 10–30 mg/L | 20–100 mg/L |
| Carbonyl control | UV and carbonyl limit | Not routinely controlled | Odour-controlled | Variable |
| Denaturant | Absent | Absent or possible methanol | Absent | May be present |
| Release basis | Ph. Eur. 2-Propanol; USP-NF Isopropyl Alcohol | ASTM D770 | Cosmetic safety dossier | Process recovery specification |